Journal
JOURNAL OF NEUROCHEMISTRY
Volume 122, Issue 5, Pages 976-994Publisher
WILEY
DOI: 10.1111/j.1471-4159.2012.07833.x
Keywords
allodynia; dorsal horn; Fc receptor; microarray; neuropathic pain; pathway analysis
Categories
Funding
- Pain and Anaesthesia Research Clinic
- Faculty of Health Sciences Divisional PhD Scholarship
- NIDA/NIH [DA024044]
- NHMRC [465423]
- Australian Research Council [DP110100297]
Ask authors/readers for more resources
J. Neurochem. (2012) 122, 976994. Abstract A quantitative, peripherally accessible biomarker for neuropathic pain has great potential to improve clinical outcomes. Based on the premise that peripheral and central immunity contribute to neuropathic pain mechanisms, we hypothesized that biomarkers could be identified from the whole blood of adult male rats, by integrating graded chronic constriction injury (CCI), ipsilateral lumbar dorsal quadrant (iLDQ) and whole blood transcriptomes, and pathway analysis with pain behavior. Correlational bioinformatics identified a range of putative biomarker genes for allodynia intensity, many encoding for proteins with a recognized role in immune/nociceptive mechanisms. A selection of these genes was validated in a separate replication study. Pathway analysis of the iLDQ transcriptome identified Fc? and Fce signaling pathways, among others. This study is the first to employ the whole blood transcriptome to identify pain biomarker panels. The novel correlational bioinformatics, developed here, selected such putative biomarkers based on a correlation with pain behavior and formation of signaling pathways with iLDQ genes. Future studies may demonstrate the predictive ability of these biomarker genes across other models and additional variables.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available